Baxter Healthcare Corporation is recalling 5,184 bags of 0.9% Sodium Chloride Injection USP (sterile saline solution), sold in 50 mL Viaflex containers, due to deviations from Current Good Manufacturing Practice (cGMP). These manufacturing failures can compromise the quality and safety of the medication, which is commonly used for intravenous hydration or to dilute other medications before administration. The recall affects specific units from lot P380063 with an expiration date of December 2019. Consumers and healthcare providers should check their supplies immediately and contact their pharmacist for a refund and guidance.
The manufacturing deviations mean the sterile solution may not have been produced under the required quality-controlled conditions, potentially leading to contamination or safety risks for patients receiving the injection. Using non-compliant injectable drugs can lead to serious adverse health consequences, including infections or adverse inflammatory reactions.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.